Leptin antagonism reduced disease severity in a preclinical animal model of rheumatoid arthritis [24], and several studies have indicated that adiponectin is involved in the progression of RA [1, 10, 21–23, 48, 49]. Here, ADIPOQ is linked to rheumatoid arthritis.